The Real World Study of BTK Inhibitor in the Treatment of Chronic Lymphocytic Leukemia in China
Clinical trial NCT06557304 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06557304
- Sponsor
- Peking University People's Hospital
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-09-01
- Primary completion
- 2026-09-01
- Enrollment
- 1000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.